Publication | Open Access

Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1)

Tumor BiologyOncologyPancreatic CancerMedicineEnhance ChemosensitivityPharmacotherapyAnti-cancer AgentPancreatic Carcinoma CellsPharmacologyCell BiologyCancer ResearchTumor MicroenvironmentMelatonin